Study the relationship between Interleukin-35 and clusterin with Mda, Gsh, Cat and Sod among male Iraqi chronic Hepatitis C patients

Abstract

Background: Chronic Hepatitis C (CHC) disease is known as a main public health problem through the world. CHC disease might lead to fibrosis of hepatocytes. In present paper, we attempted to measure whether there is any association among IL-35 and CLU with MAD, GSH, CAT and SOD, and several biochemical variables such as AST, ALT, GGT, ALP, T. BIL, and albumin. Methods: This study has included 44 patients from the Al-Fallujah Teaching Hospital, who was having CHC disease, and 44 healthy controls (HCs) were registered. Serum AST, ALT, GGT, ALP, T. BIL, albumin concentrations were estimated by colorimetric methods, IL-35 and CLU, MAD, GSH, CAT and SOD levels were estimated by ELISA technique. Results: Compared with healthy controls, the serum IL-35 and CLU, GSH, CAT and SOD concentrations were lower of patients with CHC and the serum MDA values were higher (P<0.0001, all), the serum IL-35 and CLU concentrations related positively with serum GSH, CAT, SOD and albumin, and negatively correlated with MDA, AST, ALT, GGT, ALP and T. BIL concentrations (all P<0.01). The area under the receiver operating characteristic (AUROC) curve of serum for MDA, CLU, SOD, CAT, IL-35 and GSH levels were 0.9904, 0.9403, 0.9274, 0.9246, 0.8515 and 0.82, respectively. Conclusion: Correlation among IL-35 and CLU with MAD, GSH, CAT and SOD may be attractive markers to predict disease development in CHC patients.

References

  • Abd El-Latef, T. M., Hamed, E. O., Fahem, K. Y., & Mahmoud, A. S. (2019). Serum Clusterin as a Diagnostic Tool for HCV Related Hepatocellular Carcinoma. The Medical Journal of Cairo University, 87(March), 27-32.
  • Avery, S. V. (2011). Molecular targets of oxidative stress. Biochemical Journal, 434(2), 201-210.
  • Barbaro, G., Di Lorenzo, G., Asti, A., Ribersani, M., Belloni, G., Grisorio, B., ... & Barbarini, G. (1999). Hepatocellular mitochondrial alterations in patients with chronic hepatitis C: ultrastructural and biochemical findings. The American journal of gastroenterology, 94(8), 2198-2205.
  • Bartsch, H., & Nair, J. (2006). Chronic inflammation and oxidative stress in the genesis and perpetuation of cancer: role of lipid peroxidation, DNA damage, and repair. Langenbeck’s Archives of Surgery, 391(5), 499-510.
  • Baumert T.F, Juhling F. & Ono A. (2017). Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals. BMC Med. 15(1), 52-52.
  • Chrobot, A. M., Szaflarska-Szczepanik, A., & Drewa, G. (2000). Antioxidant defense in children with chronic viral hepatitis B and C. Medical Science Monitor, 6(4), 713-718.
  • Collison, L. W., Workman, C. J., Kuo, T. T., Boyd, K., Wang, Y., Vignali, K. M., ... & Vignali, D. A. (2007). The inhibitory cytokine IL-35 contributes to regulatory T-cell function. Nature, 450(7169), 566-569.
  • De Maria, N., Colantonl, A., Fagiuoli, S., Liu, G. J., Rogers, B. K., Farinati, F., ... & Floyd, R. A. (1996). Association between reactive oxygen species and disease activity in chronic hepatitis C. Free Radical Biology and Medicine, 21(3), 291-295.
  • El-Kannishy G, Arafa M and Abdelaal I, (2012). Persistent oxidative stress in patients with chronic active hepatitis-C infection after antiviral therapy failure. Saudi J Gastroenterol. 18, 375-9.
  • Farinati, F., Cardin, R., Degan, P., De Maria, N., Floyd, R. A., Van Thiel, D. H., & Naccarato, R. (1999). Oxidative DNA damage in circulating leukocytes occurs as an early event in chronic HCV infection. Free Radical Biology and Medicine, 27(11-12), 1284-1291.
  • Fattovich, G., Stroffolini, T., Zagni, I., & Donato, F. (2004). Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology, 127(5), S35-S50.
  • Fujinaga, H., Tsutsumi, T., Yotsuyanagi, H., Moriya, K., & Koike, K. (2011). Hepatocarcinogenesis in hepatitis C: HCV shrewdly exacerbates oxidative stress by modulating both production and scavenging of reactive oxygen species. Oncology, 81(Suppl. 1), 11-17.
  • Houghton, M. (2019). Hepatitis C Virus: 30 Years after Its Discovery. Cold Spring Harbor Perspectives in Medicine, 9(12), a037069.
  • Huang, H., Chen, Y., & Ye, J. (2007). Inhibition of hepatitis C virus replication by peroxidation of arachidonate and restoration by vitamin E. Proceedings of the National Academy of Sciences, 104(47), 18666-18670.
  • Kang, Y. K., Hong, S. W., Lee, H., & Kim, W. H. (2004). Overexpression of clusterin in human hepatocellular carcinoma. Human pathology, 35(11), 1340-1346.
  • Kodydková, J., Vávrová, L., Kocík, M., & Zak, A. (2014). Human catalase, its polymorphisms, regulation and changes of its activity in different diseases. Folia biologica, 60(4), 153.
  • Li, X., Tian, L., and Dong, Y. (2015). IL-35 inhibits HBV antigen-specific IFNγ -producing CTLs in vitro. Clin.Sci.129, 395–404..
  • Liu, S., Zhang, Q., Shao, X., Wang, W., Zhang, C., & Jin, Z. (2017). An immunosuppressive function of interleukin-35 in chronic hepatitis C virus infection. International Immunopharmacology, 50, 87-94.
  • Long, J., Zhang, X., Wen, M., Kong, Q., Lv, Z., An, Y., & Wei, X. Q. (2013). IL-35 over-expression increases apoptosis sensitivity and suppresses cell growth in human cancer cells. Biochemical and biophysical research communications, 430(1), 364-369.
  • Mokhtari, E., Khamehchian, M., Montazer, G., & Nikudel, M. (2016). Landfill Site Selection Using Simple Additive Weighting (SAW) Method and Artificial Neural Network Method; A Case Study from Lorestan Province, Iran. International Journal of Geography and Geology, 5(10), 209-223.
  • Moosavy, S. H., Davoodian, P., Nazarnezhad, M. A., Nejatizaheh, A., Eftekhar, E., & Mahboobi, H. (2017). Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection. Electronic physician, 9(10), 5646.
  • Nakhjavani, M., Mashayekh, A., Khalilzadeh, O., Asgarani, F., Morteza, A., Omidi, M., & Froutan, H. (2011). Oxidized low-density lipoprotein is associated with viral load and disease activity in patients with chronic hepatitis C. Clinics and research in hepatology and gastroenterology, 35(2), 111-116.
  • Osman, H. G., Gabr, O. M., Lotfy, S., & Gabr, S. (2007). Serum levels of bcl-2 and cellular oxidative stress in patients with viral hepatitis. Indian journal of medical microbiology, 25(4), 323.
  • Ramakrishnan, G., Raghavendran, H. R. B., Vinodhkumar, R., & Devaki, T. (2006). Suppression of N-nitrosodiethylamine induced hepatocarcinogenesis by silymarin in rats. Chemico-biological interactions, 161(2), 104-114.
  • Rigoulet, M., Yoboue, E. D., & Devin, A. (2011). Mitochondrial ROS generation and its regulation: mechanisms involved in H2O2 signaling. Antioxidants & redox signaling, 14(3), 459-468.
  • Sansanwal, P., Li, L., & Sarwal, M. M. (2015). Inhibition of intracellular clusterin attenuates cell death in nephropathic cystinosis. Journal of the American Society of Nephrology, 26(3), 612-625.
  • Sevastianos, V. A., Voulgaris, T. A., & Dourakis, S. P. (2020). Hepatitis C, systemic inflammation and oxidative stress: correlations with metabolic diseases. Expert Review of Gastroenterology & Hepatology, 14(1), 27-37.
  • Shaban, N. Z., Helmy, M. H., El-Kersh, M. A., & Mahmoud, B. F. (2003). Effects of Bacillus thuringiensis toxin on hepatic lipid peroxidation and free-radical scavengers in rats given alpha-tocopherol or acetylsalicylate. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 135(4), 405-414.
  • Suzuki, Y., Imai, K., Takai, K., Hanai, T., Hayashi, H., Naiki, T., ... & Moriwaki, H. (2013). Hepatocellular carcinoma patients with increased oxidative stress levels are prone to recurrence after curative treatment: a prospective case series study using the d-ROM test. Journal of cancer research and clinical oncology, 139(5), 845-852.
  • Teng, D. K., Liu, Y., Lv, Y. F., Wang, L., Zhang, W., Wang, J. P., & Li, Y. (2019). Elevated interleukin-35 suppresses liver inflammation by regulation of T helper 17 cells in acute hepatitis B virus infection. International immunopharmacology, 70, 252-259.
  • Trevisani, F., Caraceni, P., Simoncini, M., Micati, M., Domenicali, M., Dazzani, F., ... & Guarnieri, C. (2002). Evidence of oxidative imbalance in long-term liver transplant patients. Digestive and Liver Disease, 34(4), 279-284.
  • Wang, Y., Liu, Y. H., Mai, S. J., He, L. J., Liao, Y. J., Deng, H. X., ... & Xie, D. (2010). Evaluation of serum clusterin as a surveillance tool for human hepatocellular carcinoma with hepatitis B virus related cirrhosis. Journal of gastroenterology and hepatology, 25(6), 1123-1128.
  • Wisniewska-Ligier, M., Wozniakowska-Gesicka, T., & Lewkowicz, P., (2004). Neutrophil oxidative metabolism in children with chronic hepatitis C. Przegl Lek, 61, 1338-1341.
  • Xiang, X. G., & Xie, Q. (2015). IL‐35: a potential therapeutic target for controlling hepatitis B virus infection. Journal of digestive diseases, 16(1), 1-6.
  • Yamane, D., McGivern, D. R., Wauthier, E., Yi, M., Madden, V. J., Welsch, C., ... & Widman, D. G. (2014). Regulation of the hepatitis C virus RNA replicase by endogenous lipid peroxidation. Nature medicine, 20(8), 927-935.
  • Zhang, J., Zhang, Y., Wang, Q., Li, C., Deng, H., Si, C., & Xiong, H. (2019). Interleukin‐35 in immune‐related diseases: protection or destruction. Immunology, 157(1), 13-20.

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.